Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001595585-20-000010
Filing Date
2020-02-05
Accepted
2020-02-05 21:29:32
Documents
1
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158095615522796.html 4  
1 FORM 4 wf-form4_158095615522796.xml 4 10611
  Complete submission text file 0001595585-20-000010.txt   12000
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRICIDA, INC. 7000 SHORELINE COURT, SUITE 201 PALO ALTO CA 94080
Business Address
HEJLEK EDWARD J (Reporting) CIK: 0001743664 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 20580686